Cox regression of cardiovascular events and cardiovascular event-free survival for ESA-treated vs untreated patients, adjusted for confounders
| . | HR . | 95% CI . | P . |
|---|---|---|---|
| Cardiovascular event | |||
| Unadjusted | |||
| ESA treatment | 1.28 | 0.68-2.42 | .445 |
| Adjusted* | |||
| ESA treatment | 1.24 | 0.66-2.34 | .507 |
| Presence of another cytopenia | 1.92 | 1.07-3.42 | .028 |
| Cardiovascular event or death | |||
| Unadjusted | |||
| ESA treatment | 1.21 | 0.88-1.66 | .234 |
| Adjusted† | |||
| ESA treatment | 0.94 | 0.67-1.31 | .693 |
| Presence of another cytopenia | 2.06 | 1.54-2.75 | < .001 |
| Hemoglobin, g/L | 0.98 | 0.97-0.99 | < .001 |
| Age, years | 1.03 | 1.01-1.06 | .001 |
| Male sex | 1.55 | 1.15-2.08 | .004 |
| Comorbidity index | 1.13 | 1.03-1.23 | .006 |
| . | HR . | 95% CI . | P . |
|---|---|---|---|
| Cardiovascular event | |||
| Unadjusted | |||
| ESA treatment | 1.28 | 0.68-2.42 | .445 |
| Adjusted* | |||
| ESA treatment | 1.24 | 0.66-2.34 | .507 |
| Presence of another cytopenia | 1.92 | 1.07-3.42 | .028 |
| Cardiovascular event or death | |||
| Unadjusted | |||
| ESA treatment | 1.21 | 0.88-1.66 | .234 |
| Adjusted† | |||
| ESA treatment | 0.94 | 0.67-1.31 | .693 |
| Presence of another cytopenia | 2.06 | 1.54-2.75 | < .001 |
| Hemoglobin, g/L | 0.98 | 0.97-0.99 | < .001 |
| Age, years | 1.03 | 1.01-1.06 | .001 |
| Male sex | 1.55 | 1.15-2.08 | .004 |
| Comorbidity index | 1.13 | 1.03-1.23 | .006 |